<DOC>
	<DOCNO>NCT00557128</DOCNO>
	<brief_summary>This randomize , open-label , single-dose , period-balanced , three-period crossover study conduct healthy subject design evaluate whether absorption FDC formulation affect ingestion high fat meal alter take fasted state .</brief_summary>
	<brief_title>Study Examine Effect Food Pharmacokinetics Fixed Dose Combination COREG CR Lisinopril .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Inclusion criterion : Healthy volunteer Adult male females nonchild bear potential 18 55 year age , inclusively Body weight &gt; 60 kg ( 132 lb ) body mass index ( BMI ) 19 33 Exclusion criterion : Any clinically relevant abnormality identify screen history , physical laboratory examination , medical condition circumstance make volunteer unsuitable participation study . Subjects metabolize carvedilol poorly base CYP2D6 genotyping determine screen . Treatment prescription nonprescription drug ( include vitamin , herbal dietary supplement , well grapefruitcontaining product ) within 7 day 5 halflives ( whichever longer ) prior first dose study medication end study . Treatment CYP2D6 inhibitor limit quinidine , fluoxetine , paroxetine , duloxetine , terbinofine least 14 day 5 halflives ( whichever longer ) prior Day 1 Session 1 end study . Treatment investigational drug within 30 day 5 halflives ( whichever longer ) precede Day 1 Session 1 Exposure four new chemical entity within 12 month prior first dose day . History regular alcohol consumption exceed 7 drinks/week woman 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month screen . Positive urine drug screen ( UDS ) include alcohol screening . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine . Urine Na/creatinine ratio &lt; 0.08 meq/mg . Positive Hepatitis B surface antigen , HIV . Women childbearing potential . NOTE : Premenopausal female document tubal ligation hysterectomy eligible . Postmenopausal females eligible , define 12 month spontaneous amenorrhea ( questionable case blood sample simultaneous follicle stimulate hormone ( FSH ) &gt; 40 MlU/ml estradiol &lt; 40 pg/ml ( &lt; 140 pmol/L ) confirmatory ] . Resting heart rate ≤ 50 beat per minute ( bpm ) screening . Any following abnormality 12lead ECG screening : conduction abnormality denote follow : PR interval &lt; 120 msec &gt; 200 msec nonspecific IVCD ( intraventricular conduction delay ) QRS duration ≥ 110 msec morphology NOT meet criterion leave ( LBBB ) right bundle branch block ( RBBB ) incomplete RBBB define QRS duration ≥100 msec &lt; 120 msec RBBB pattern Complete RBBB LBBB evidence second third degree AV block pathological Qwaves ( Qwave wider 0.04 sec depth great 0.40.5 mV ) evidence ventricular preexcitation evidence leave axis deviation ( left axis deviation 30 90 degree ) normal leftward axis , STT wave abnormality , leave bundle branch block and/or right bundle branch block QTcB interval &gt; 450 msec Documented history low blood pressure ( average SBP ≤ 110 mm Hg and/or DBP ≤ 50 mm Hg ) blood pressure value time screen . Orthostatic hypotension diagnose screening ( orthostatic hypotension define reduction systolic blood pressure 20 mmHg and/or reduction diastolic blood pressure 10 mmHg stand vs. supine measurement . Donation blood excess 500 mL within 56day period include estimate 442 mL blood drawn study . History asthma , COPD and/or hypersensitivity βadrenergic block agent . History sensitivity heparin , heparininduced thrombocytopenia , sensitivity study medication component thereof . History anaphylaxis anaphalactoid reaction severe allergic response drug . History angioedema . History sensitivity carvedilol , lisinopril , alphablockers , betablockers ACE inhibitor . Unwillingness inability follow procedure outline protocol inability provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>COREG CR ,</keyword>
	<keyword>lisinopril ,</keyword>
	<keyword>hypertension ,</keyword>
	<keyword>dose proportionality ,</keyword>
	<keyword>fix dose combination ( FDC )</keyword>
</DOC>